UNSPSC 51372038: Morphine sulfate pentahydrate

This classification denotes an opiate with the molecular formula 2C17H19NO3.5H2O.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X3P646A2J0, chemically known as morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl, (5.alpha.,6.alpha.)-, sulfate (2:1) (salt), pentahydrate, but more generally known as morphine sulfate pentahydrate, which bears US NIH Compound Identifier 6436139.

European Medicines Agency schedules morphine sulfate pentahydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03332MIG. Most nations, for tariff purposes, schedule morphine sulfate pentahydrate under HS 29391100. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O.CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O.O.O.O.O.O.OS(=O)(=O)O.

UNSPSC 51372038 Morphine sulfate pentahydrate is a Commodity code covering pharmaceutical products that state and local governments procure through health and human services channels. The code's nominal scope—a specific opioid formulation—does not align with the actual work being solicited under it in recent state and local opportunities. Recent postings show state and local buyers acquiring naloxone, multi-source generic pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing vehicles, not morphine sulfate specifically. The issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. These agencies acquire pharmaceutical inventories to support community health initiatives, pharmacy benefit programs, and public-health interventions like opioid overdose response.

Activity spans Florida, Texas, Minnesota, and Oregon, with representation from Seminole County (IFB for naloxone and drug deactivation systems, posted June 30, 2026, due July 26, 2023), the Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescription programs, posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance (RFP for generic multi-source pharmaceuticals and OTC products, posted January 20, 2026, due March 26, 2026). The Minnesota cooperative purchasing vehicle is particularly active, requiring vendors to work through authorized wholesalers and certifying compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. The code shows little direct activity for morphine sulfate pentahydrate as a standalone procured item; the tagging appears to reflect a data-classification mismatch rather than genuine morphine-specific demand in recent state and local opportunities.